Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
8.80
+0.02 (0.23%)
At close: Apr 28, 2026, 4:00 PM EDT
8.68
-0.12 (-1.36%)
After-hours: Apr 28, 2026, 4:15 PM EDT
Rallybio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 0.86 | 0.64 | - | - | - | |
| Revenue Growth (YoY) | 34.91% | - | - | - | - | |
| Cost of Revenue | 18.4 | 39.51 | 53.54 | - | - | |
| Gross Profit | -17.54 | -38.87 | -53.54 | - | - | |
| Selling, General & Admin | 13.83 | 18.33 | 25.39 | 27.2 | 18.74 | |
| Research & Development | - | - | - | 40.69 | 26.91 | |
| Operating Expenses | 13.83 | 18.33 | 25.39 | 67.88 | 45.65 | |
| Operating Income | -31.36 | -57.2 | -78.93 | -67.88 | -45.65 | |
| Interest Expense | - | - | - | - | -0.01 | |
| Interest & Investment Income | 2.19 | 4.22 | 6.15 | 1.96 | 0.05 | |
| Earnings From Equity Investments | -0.87 | -2.24 | -2.04 | -1.08 | -1.51 | |
| Other Non Operating Income (Expenses) | 0.42 | 0.74 | 0.26 | 0.34 | 0.1 | |
| EBT Excluding Unusual Items | -29.63 | -54.48 | -74.56 | -66.65 | -47.01 | |
| Merger & Restructuring Charges | -1.7 | -3.3 | - | - | - | |
| Gain (Loss) on Sale of Investments | 22.35 | - | - | - | - | |
| Pretax Income | -8.98 | -57.78 | -74.56 | -66.65 | -47.01 | |
| Net Income | -8.98 | -57.78 | -74.56 | -66.65 | -47.01 | |
| Net Income to Common | -8.98 | -57.78 | -74.56 | -66.65 | -47.01 | |
| Shares Outstanding (Basic) | 6 | 5 | 5 | 4 | 3 | |
| Shares Outstanding (Diluted) | 6 | 5 | 5 | 4 | 3 | |
| Shares Change (YoY) | 3.42% | 7.66% | 27.11% | 24.70% | 46.76% | |
| EPS (Basic) | -1.59 | -10.61 | -14.75 | -16.76 | -14.74 | |
| EPS (Diluted) | -1.59 | -10.61 | -14.75 | -16.76 | -14.74 | |
| Free Cash Flow | -29.81 | -49.28 | -60.28 | -57.34 | -45.87 | |
| Free Cash Flow Per Share | -5.30 | -9.05 | -11.92 | -14.41 | -14.38 | |
| Operating Margin | -3655.48% | -8993.08% | - | - | - | |
| Profit Margin | -1046.39% | -9084.12% | - | - | - | |
| Free Cash Flow Margin | -3474.71% | -7748.74% | - | - | - | |
| EBITDA | -31.27 | -57.07 | -78.78 | -67.72 | -45.54 | |
| D&A For EBITDA | 0.09 | 0.13 | 0.15 | 0.17 | 0.11 | |
| EBIT | -31.36 | -57.2 | -78.93 | -67.88 | -45.65 | |
| Revenue as Reported | 0.86 | 0.64 | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.